Approval for the 11 mm and 15 mm biodivysio(tm) as otw.  The device, as modified, will be marketed under the trade name biodivysio(tm) as otw and is indicated for: "use in subjects with symptomatic ischemic heart disease due to de novo native coronary artery lesions (length <= 25 mm) with a reference vessel diameter ranging from >= 3.0 mm to <= 4.0 mm and intended to improve coronary lumen diameter.  Long term outcome (beyond 6 months) for this permanent implant is unknown at present."